|
Index of reports
> Cases resulting in death (47)
> Cases with Blood Glucose Increased (9)
Below is the selection of adverse event reports related to Actos (Pioglitazone) that includes cases resulting in death where reactions include blood glucose increased.
Adverse event in 49 year old male receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from Korea, Republic of on 2007-06-26
Patient: 49 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Sudden Death, Blood Cholesterol Increased, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl; Thioctacid (Thioctic Acid); Pentoxifylline; Saccharomyces Medicinalis; Otilonium Bromide
Adverse event in 74 year old female receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from Korea, Republic of on 2007-06-19
Patient: 74 year old female
Adverse reactions / side effects: Cardiac Disorder, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl
Adverse event in 66 year old female receiving Actos (Pioglitazone)
Reported by a physician from Korea, Republic of on 2007-06-19
Patient: 66 year old female
Adverse reactions / side effects: Glycosylated Haemoglobin Increased, Hepatic Neoplasm Malignant, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl
Adverse event in 74 year old male receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from Korea, Republic of on 2007-06-12
Patient: 74 year old male
Adverse reactions / side effects: Cardiac Disorder, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl
Adverse event in 66 year old female receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from Korea, Republic of on 2007-06-12
Patient: 66 year old female
Adverse reactions / side effects: Glycosylated Haemoglobin Increased, Hepatic Neoplasm Malignant, Blood Cholesterol Increased, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl
Adverse event in 49 year old male receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from Korea, Republic of on 2007-06-12
Patient: 49 year old male
Adverse reactions / side effects: Sudden Death, Blood Cholesterol Increased, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Actos (Pioglitazone)
Other drugs received by patient: Amaryl; Thioctacid (Thioctic Acid); Pentoxifylline; Saccharomyces Medicinalis
Adverse event in 65 year old male receiving Actos (Pioglitazone)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-02-26
Patient: 65 year old male
Adverse reactions / side effects: Ultrasound Scan Abnormal, Alanine Aminotransferase Increased, Incorrect Dose Administered, Skin Disorder, High Density Lipoprotein Decreased, Flushing, Haemoglobin Decreased, Glycosylated Haemoglobin Increased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Depressed Level of Consciousness, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once;po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Effexor XR
Dosage: 150 mg q day; po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day;po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day;sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day;sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df;
End date: 2006-06-11
Tenormin
Dosage: 1000 mg q day;po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day;po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day;po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg; po
Administration route: Oral
Multi-Vitamins
Dosage: df;
Adverse event in 65 year old male receiving Actos (Pioglitazone)
Reported by a physician from United States on 2007-02-16
Patient: 65 year old male, weighing 94.8 kg (208.6 pounds)
Adverse reactions / side effects: Flushing, Cardio-Respiratory Arrest, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: Blood Cholesterol Increased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg qd po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg qd po
Administration route: Oral
Indication: Depression
Effexor
Dosage: 150 mg daily po
Administration route: Oral
Indication: Depression
Lorazepam
Dosage: 2 mg qd po
Administration route: Oral
Indication: Depression
Trazodone HCL
Dosage: 200 mg qd po
Administration route: Oral
Indication: Depression
Tenormin
Dosage: 100 mg qd po
Administration route: Oral
Indication: Tachyarrhythmia
Lanoxin
Dosage: 0.375 mg qd po
Administration route: Oral
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Glucotrol XL
Dosage: 10 mg qd po
Administration route: Oral
Actos
Dosage: 45 mg qd po
Administration route: Oral
Tricor
Dosage: 160 mg qd po
Administration route: Oral
Lantus
Dosage: 70 qd sc
Start date: 2006-06-09
Lipitor
Vitamin CAP
Risperdal
Dosage: 3 mg po
Administration route: Oral
Adverse event in 65 year old male receiving Actos (Pioglitazone)
Reported by a individual with unspecified qualification from United States on 2007-02-07
Patient: 65 year old male
Adverse reactions / side effects: Alanine Aminotransferase Increased, Pallor, High Density Lipoprotein Decreased, Hepatic Steatosis, Flushing, Haemoglobin Decreased, Cardio-Respiratory Arrest, Aspartate Aminotransferase Increased, Myocardial Infarction, Blood Glucose Increased
Adverse event resulted in: death
Suspect drug(s):
Lorazepam
Dosage: 2 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 1000 mg once po
Administration route: Oral
Indication: Hypercholesterolaemia
Start date: 2006-06-11
End date: 2006-06-11
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: High Density Lipoprotein Decreased
Niaspan
Dosage: 500 mg q day po
Administration route: Oral
Indication: Hypercholesterolaemia
Effexor XR
Dosage: 150 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Actos
Dosage: 45 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucophage
Dosage: 1000 mg bid po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Glucotrol XL
Dosage: 10 mg q day po
Administration route: Oral
Indication: Diabetes Mellitus
End date: 2006-06-11
Lanoxin
Dosage: 0.375 g q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Lantus
Dosage: 70 u q day sc
Indication: Diabetes Mellitus
Start date: 2006-06-09
End date: 2006-06-11
Lantus
Dosage: 65 u q day sc
Indication: Diabetes Mellitus
End date: 2006-06-08
Lipitor
Dosage: df
End date: 2006-06-11
Tenormin
Dosage: 100 mg q day po
Administration route: Oral
Indication: Tachyarrhythmia
End date: 2006-06-11
Trazodone HCL
Dosage: 200 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Tricor
Dosage: 160 mg q day po
Administration route: Oral
Indication: Dyslipidaemia
End date: 2006-06-11
Wellbutrin
Dosage: 300 mg q day po
Administration route: Oral
Indication: Depression
End date: 2006-06-11
Risperdal
Dosage: 3 mg po
Administration route: Oral
Vitamin CAP
Dosage: df
|
